{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BMPR2", "PAH", "bone morphogenetic protein receptor type 2", "genes", "mutations", "pulmonary arterial hypertension"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33732008", "DateRevised": {"Year": "2021", "Month": "03", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.2147/TACG.S260755"], "Journal": {"ISSN": "1178-704X", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2021"}}, "Title": "The application of clinical genetics", "ISOAbbreviation": "Appl Clin Genet"}, "ArticleTitle": "Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension.", "Pagination": {"StartPage": "113", "EndPage": "124", "MedlinePgn": "113-124"}, "Abstract": {"AbstractText": ["Pulmonary Arterial Hypertension (PAH) is a progressive and devastating disease for which there is an escalating body of genetic and related pathophysiological information on disease pathobiology. Nevertheless, the success to date in identifying susceptibility genes, genetic variants and epigenetic processes has been limited due to PAH clinical multi-faceted variations. A number of germline gene candidates have been proposed but demonstrating consistently the association with PAH has been problematic, at least partly due to the reduced penetrance and variable expressivity. Although the data for bone morphogenetic protein receptor type 2 (BMPR2) and related genes remains undoubtedly the most extensive, recent advanced gene sequencing technologies have facilitated the discovery of further gene candidates with mutations among those with and without familial forms of PAH. An in depth understanding of the multitude of biologic variations associated with PAH may provide novel opportunities for therapeutic intervention in the coming years. This knowledge will irrevocably provide the opportunity for improved patient and family counseling as well as improved PAH diagnosis, risk assessment, and personalized treatment."], "CopyrightInformation": "\u00a9 2021 Egom et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut du Savoir Montfort (ISM), H\u00f4pital Montfort, Ottawa, ON, Canada."}, {"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Reflex Medical Centre Cardiac Diagnostics, Reflex Medical Centre, Mississauga, ON, Canada."}], "LastName": "Egom", "ForeName": "Emmanuel Eroume-A", "Initials": "EE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Moyou-Somo", "ForeName": "Roger", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Essame Oyono", "ForeName": "Jean Louis", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Endocrinology and Radioisotopes, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9, Cameroon."}], "LastName": "Kamgang", "ForeName": "Rene", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Appl Clin Genet", "NlmUniqueID": "101579789", "ISSNLinking": "1178-704X"}, "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S. Pathology of pulmonary hypertension. Clin Chest Med. 2007;28(1):23\u201342. doi:10.1016/j.ccm.2006.11.010", "ArticleIdList": ["10.1016/j.ccm.2006.11.010", "PMC1924722", "17338926"]}, {"Citation": "Gali\u00e8 N, Simonneau G. The Fifth World Symposium on Pulmonary Hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D1\u2013d3.", "ArticleIdList": ["24355633"]}, {"Citation": "Austin ED, Loyd JE. The genetics of pulmonary arterial hypertension. Circ Res. 2014;115(1):189\u2013202.", "ArticleIdList": ["PMC4137413", "24951767"]}, {"Citation": "Gali\u00e8 N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019;53:1.", "ArticleIdList": ["PMC6351332", "30552088"]}, {"Citation": "Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122(2):156\u2013163.", "ArticleIdList": ["20585011"]}, {"Citation": "Rich S, Pogoriler J, Husain AN, Toth PT, Gomberg-Maitland M, Archer SL. Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension. Chest. 2010;138(5):1234\u20131239.", "ArticleIdList": ["PMC2972625", "21051399"]}, {"Citation": "Dresdale DT, Schultz M, Michtom RJ. Primary pulmonary hypertension. I. Clinical and hemodynamic study. Am J Med. 1951;11(6):686\u2013705.", "ArticleIdList": ["14902839"]}, {"Citation": "Dresdale DT, Michtom RJ, Schultz M. Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance. Bull N Y Acad Med. 1954;30(3):195\u2013207.", "ArticleIdList": ["PMC1804415", "13141055"]}, {"Citation": "Tang H, Desai AA, Yuan JX-J. Genetic Insights into Pulmonary Arterial Hypertension. Application of Whole-Exome Sequencing to the Study of Pathogenic Mechanisms. Am J Respir Crit Care Med. 2016;194(4):393\u2013397. doi:10.1164/rccm.201603-0577ED", "ArticleIdList": ["10.1164/rccm.201603-0577ED", "PMC5003333", "27525458"]}, {"Citation": "Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis. 1984;129(1):194\u2013197. doi:10.1164/arrd.1984.129.1.194", "ArticleIdList": ["10.1164/arrd.1984.129.1.194", "6703480"]}, {"Citation": "Loyd JE, Slovis B, Phillips JA 3rd, et al. The presence of genetic anticipation suggests that the molecular basis of familial primary pulmonary hypertension may be trinucleotide repeat expansion. Chest. 1997;111(6 Suppl):82s\u201383s.", "ArticleIdList": ["PMC6767907", "9184540"]}, {"Citation": "Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S43\u2013S54.", "ArticleIdList": ["19555858"]}, {"Citation": "Larkin EK, Newman JH, Austin ED, et al. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(9):892\u2013896.", "ArticleIdList": ["PMC3530218", "22923661"]}, {"Citation": "Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet. 2000;26(1):81\u201384.", "ArticleIdList": ["10973254"]}, {"Citation": "Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107(2):216\u2013223.", "ArticleIdList": ["3605900"]}, {"Citation": "Machado RD, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S32\u2013S42.", "ArticleIdList": ["PMC3725550", "19555857"]}, {"Citation": "Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67(3):737\u2013744.", "ArticleIdList": ["PMC1287532", "10903931"]}, {"Citation": "Hamid R, Cogan JD, Hedges LK, et al. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele. Hum Mutat. 2009;30(4):649\u2013654.", "ArticleIdList": ["PMC2663001", "19206171"]}, {"Citation": "Austin ED, Hamid R, Hemnes AR, et al. BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differ. 2012;3(1):6.", "ArticleIdList": ["PMC3310853", "22348410"]}, {"Citation": "Sztrymf B, Coulet F, Girerd B, et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med. 2008;177(12):1377\u20131383.", "ArticleIdList": ["18356561"]}, {"Citation": "Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996;13(2):189\u2013195.", "ArticleIdList": ["8640225"]}, {"Citation": "McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994;8(4):345\u2013351.", "ArticleIdList": ["7894484"]}, {"Citation": "Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685\u2013700.", "ArticleIdList": ["12809600"]}, {"Citation": "Fern\u00e1ndez LA, Sanz-Rodriguez F, Blanco FJ, Bernab\u00e9u C, Botella LM. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res. 2006;4(1):66\u201378.", "ArticleIdList": ["PMC1435660", "16595794"]}, {"Citation": "Shintani M, Yagi H, Nakayama T, Saji T, Matsuoka R. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J Med Genet. 2009;46(5):331\u2013337.", "ArticleIdList": ["19211612"]}, {"Citation": "Nasim MT, Ogo T, Ahmed M, et al. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat. 2011;32(12):1385\u20131389.", "ArticleIdList": ["21898662"]}, {"Citation": "Drake KM, Zygmunt D, Mavrakis L, et al. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Am J Respir Crit Care Med. 2011;184(12):1400\u20131408.", "ArticleIdList": ["PMC3262031", "21920918"]}, {"Citation": "Good RB, Gilbane AJ, Trinder SL, et al. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am J Pathol. 2015;185(7):1850\u20131858.", "ArticleIdList": ["25956031"]}, {"Citation": "Harrison RE, Flanagan JA, Sankelo M, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet. 2003;40(12):865\u2013871.", "ArticleIdList": ["PMC1735342", "14684682"]}, {"Citation": "Austin ED, Ma L, LeDuc C, et al. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet. 2012;5(3):336\u2013343.", "ArticleIdList": ["PMC3380156", "22474227"]}, {"Citation": "Ma L, Roman-Campos D, Austin ED, et al. A novel channelopathy in pulmonary arterial hypertension. N Engl J Med. 2013;369(4):351\u2013361.", "ArticleIdList": ["PMC3792227", "23883380"]}, {"Citation": "Olschewski A, Li Y, Tang B, et al. Impact of TASK-1 in human pulmonary artery smooth muscle cells. Circ Res. 2006;98(8):1072\u20131080.", "ArticleIdList": ["16574908"]}, {"Citation": "Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol. 2004;142(1):192\u2013202.", "ArticleIdList": ["PMC1574915", "15066906"]}, {"Citation": "Osipenko ON, Evans AM, Gurney AM. Regulation of the resting potential of rabbit pulmonary artery myocytes by a low threshold, O2-sensing potassium current. Br J Pharmacol. 1997;120(8):1461\u20131470.", "ArticleIdList": ["PMC1564630", "9113366"]}, {"Citation": "Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res. 2003;93(10):957\u2013964.", "ArticleIdList": ["14551239"]}, {"Citation": "Remillard CV, Tigno DD, Platoshyn O, et al. Function of Kv1. 5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol. 2007;292(5):C1837\u2013C1853.", "ArticleIdList": ["17267549"]}, {"Citation": "Moudgil R, Michelakis ED, Archer SL. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation. 2006;13(8):615\u2013632.", "ArticleIdList": ["17085423"]}, {"Citation": "Ai J, Liu M, Shuai Z, et al. KCNA5 gene variation is not associated with the pulmonary hypertension in systemic sclerosis patients. 2019."}, {"Citation": "Quest AF, Leyton L, P\u00e1rraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol. 2004;82(1):129\u2013144.", "ArticleIdList": ["15052333"]}, {"Citation": "Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001;293(5539):2449\u20132452.", "ArticleIdList": ["11498544"]}, {"Citation": "Garg A, Kircher M, Del Campo M, Amato RS, Agarwal AK. Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome. Am J Med Genet A. 2015;167a(8):1796\u20131806.", "ArticleIdList": ["PMC5086082", "25898808"]}, {"Citation": "Hartung A, Bitton-Worms K, Rechtman MM, et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol. 2006;26(20):7791\u20137805.", "ArticleIdList": ["PMC1636853", "16923969"]}, {"Citation": "Wertz JW, Bauer PM. Caveolin-1 regulates BMPRII localization and signaling in vascular smooth muscle cells. Biochem Biophys Res Commun. 2008;375(4):557\u2013561.", "ArticleIdList": ["18725205"]}, {"Citation": "Meloche J, Courchesne A, Barrier M, et al. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc. 2013;2(1):e005157.", "ArticleIdList": ["PMC3603259", "23525442"]}, {"Citation": "Maniatis NA, Shinin V, Schraufnagel DE, et al. Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice. Am J Physiol Lung Cell Mol Physiol. 2008;294(5):L865\u2013L873.", "ArticleIdList": ["18192592"]}, {"Citation": "Bauer PM, Yu J, Chen Y, et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A. 2005;102(1):204\u2013209.", "ArticleIdList": ["PMC544041", "15615855"]}, {"Citation": "Zhao YY, Liu Y, Stan RV, et al. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A. 2002;99(17):11375\u201311380.", "ArticleIdList": ["PMC123264", "12177436"]}, {"Citation": "Bauer PM, Bauer EM, Rogers NM, et al. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. Cardiovasc Res. 2012;93(4):682\u2013693.", "ArticleIdList": ["PMC3291089", "22215724"]}, {"Citation": "Zhao YY, Zhao YD, Mirza MK, et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009;119(7):2009\u20132018.", "ArticleIdList": ["PMC2701851", "19487814"]}, {"Citation": "Eyries M, Montani D, Girerd B, et al. Familial pulmonary arterial hypertension by KDR heterozygous loss of function. Eur Respir J. 2020;55:4.", "ArticleIdList": ["31980491"]}, {"Citation": "Chida A, Shintani M, Matsushita Y, et al. Mutations of NOTCH3 in childhood pulmonary arterial hypertension. Mol Genet Genom Med. 2014;2(3):229\u2013239.", "ArticleIdList": ["PMC4049363", "24936512"]}, {"Citation": "T\u00f8rring PM, Brusgaard K, Ousager LB, Andersen PE, Kjeldsen AD. National mutation study among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2014;86(2):123\u2013133.", "ArticleIdList": ["24001356"]}, {"Citation": "Gallione CJ, Richards JA, Letteboer TG, et al. SMAD4 mutations found in unselected HHT patients. J Med Genet. 2006;43(10):793\u2013797.", "ArticleIdList": ["PMC2563178", "16613914"]}, {"Citation": "Tillet E, Bailly S. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. Front Genet. 2014;5:456.", "ArticleIdList": ["PMC4288046", "25620979"]}, {"Citation": "Wooderchak-Donahue WL, McDonald J, O\u2019Fallon B, et al. BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet. 2013;93(3):530\u2013537.", "ArticleIdList": ["PMC3769931", "23972370"]}, {"Citation": "Wang G, Fan R, Ji R, et al. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report. BMC Pulm Med. 2016;16:17.", "ArticleIdList": ["PMC4722683", "26801773"]}, {"Citation": "Wang X-J, Lian T-Y, Jiang X, et al. Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension. Eur Respir J. 2019;53:3.", "ArticleIdList": ["30578397"]}, {"Citation": "Abdalla SA, Cymerman U, Rushlow D, et al. Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia. Hum Mutat. 2005;25(3):320\u2013321.", "ArticleIdList": ["15712271"]}, {"Citation": "Prigoda NL, Savas S, Abdalla SA, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet. 2006;43(9):722\u2013728.", "ArticleIdList": ["PMC2564570", "16690726"]}, {"Citation": "Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001;345(5):325\u2013334.", "ArticleIdList": ["11484689"]}, {"Citation": "Greenwald J, Fischer WH, Vale WW, Choe S. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat Struct Biol. 1999;6(1):18\u201322.", "ArticleIdList": ["9886286"]}, {"Citation": "Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34\u2013D41.", "ArticleIdList": ["24355639"]}, {"Citation": "Eyries M, Montani D, Girerd B, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet. 2014;46(1):65\u201369.", "ArticleIdList": ["24292273"]}, {"Citation": "Best DH, Sumner KL, Austin ED, et al. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest. 2014;145(2):231\u2013236.", "ArticleIdList": ["PMC3921094", "24135949"]}, {"Citation": "Gr\u00fcnig E, Koehler R, Miltenberger-Miltenyi G, et al. Primary pulmonary hypertension in children may have a different genetic background than in adults. Pediatr Res. 2004;56(4):571\u2013578.", "ArticleIdList": ["15295086"]}, {"Citation": "Chida A, Shintani M, Yagi H, et al. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers. Am J Cardiol. 2012;110(4):586\u2013593.", "ArticleIdList": ["22632830"]}, {"Citation": "Thomson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet. 2000;37(10):741\u2013745.", "ArticleIdList": ["PMC1757155", "11015450"]}, {"Citation": "Pfarr N, Fischer C, Ehlken N, et al. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension. Respir Res. 2013;14(1):3.", "ArticleIdList": ["PMC3547748", "23298310"]}, {"Citation": "Rosenzweig EB, Morse JH, Knowles JA, et al. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant. 2008;27(6):668\u2013674.", "ArticleIdList": ["18503968"]}, {"Citation": "Kerstjens-Frederikse WS, Bongers EM, Roofthooft MT, et al. TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. J Med Genet. 2013;50(8):500\u2013506.", "ArticleIdList": ["PMC3717587", "23592887"]}, {"Citation": "Zhu N, Gonzaga-Jauregui C, Welch CL, et al. Exome sequencing in children with pulmonary arterial hypertension demonstrates differences compared with adults. Circulation. 2018;11(4):e001887.", "ArticleIdList": ["PMC5896781", "29631995"]}, {"Citation": "Haarman MG, Kerstjens-Frederikse WS, Vissia-Kazemier TR, et al. The genetic epidemiology of pediatric pulmonary arterial hypertension. J Pediatr. 2020;225:65\u201373.e65.", "ArticleIdList": ["32502478"]}, {"Citation": "Navas P, Tenorio J, Quezada CA, et al. Molecular Analysis of BMPR2, TBX4, and KCNK3 and genotype-phenotype correlations in Spanish patients and families with idiopathic and hereditary pulmonary arterial hypertension. Revista Espanola De Cardiologia. 2016;69(11):1011\u20131019.", "ArticleIdList": ["27453251"]}, {"Citation": "Bohnen MS, Ma L, Zhu N, et al. Loss-of-Function ABCC8 mutations in pulmonary arterial hypertension. Circ Genom Precision Med. 2018;11(10):e002087.", "ArticleIdList": ["PMC6206877", "30354297"]}, {"Citation": "Gr\u00e4f S, Haimel M, Bleda M, et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018;9(1):1\u201316.", "ArticleIdList": ["PMC5897357", "29650961"]}, {"Citation": "Hodgson J, Swietlik EM, Salmon RM, et al. Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020;201(5):575\u2013585.", "ArticleIdList": ["PMC7047445", "31661308"]}, {"Citation": "Long L, Ormiston ML, Yang X, et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med. 2015;21(7):777\u2013785.", "ArticleIdList": ["PMC4496295", "26076038"]}, {"Citation": "Chida A, Shintani M, Nakayama T, et al. Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension. Circ j. 2012;76(6):1501\u20131508.", "ArticleIdList": ["22374147"]}, {"Citation": "Takeda M, Otsuka F, Nakamura K, et al. Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action. Endocrinology. 2004;145(9):4344\u20134354.", "ArticleIdList": ["15192043"]}, {"Citation": "Rostama B, Peterson SM, Vary CP, Liaw L. Notch signal integration in the vasculature during remodeling. Vascul Pharmacol. 2014;63(2):97\u2013104.", "ArticleIdList": ["PMC4304902", "25464152"]}, {"Citation": "Pousada G, Baloira A, Valverde D. Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations. Sci Rep. 2016;6:33570.", "ArticleIdList": ["PMC5024326", "27630060"]}, {"Citation": "Egom EE, Feridooni T, Pharithi RB, et al. A natriuretic peptides clearance receptor\u2019s agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: new hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomed Pharmacother. 2017;93:1144\u20131150.", "ArticleIdList": ["28738523"]}, {"Citation": "Egom EE, Feridooni T, Pharithi RB, et al. New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int J Physiol Pathophysiol Pharmacol. 2017;9(4):112\u2013118.", "ArticleIdList": ["PMC5592245", "28951773"]}, {"Citation": "Egom EE, Maher V, El Hiani Y. Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure. Int J Cardiol. 2019;281:172\u2013178.", "ArticleIdList": ["29885823"]}, {"Citation": "Egom EE-A. Pulmonary Arterial Hypertension Due to NPR-C Mutation: a Novel Paradigm for Normal and Pathologic Remodeling? Int J Mol Sci. 2019;20(12):3063.", "ArticleIdList": ["PMC6628360", "31234560"]}, {"Citation": "Egom EE. BNP and Heart Failure: preclinical and Clinical Trial Data. J Cardiovasc Transl Res. 2015;8(3):149\u2013157.", "ArticleIdList": ["25771949"]}, {"Citation": "Matzuk MM, Kumar TR, Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 1995;374(6520):356\u2013360.", "ArticleIdList": ["7885474"]}, {"Citation": "Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. j Biochemistry. 2010;147(1):35\u201351.", "ArticleIdList": ["19762341"]}, {"Citation": "Oh SP, Li E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 1997;11(14):1812\u20131826.", "ArticleIdList": ["9242489"]}, {"Citation": "Pousada G, Lupo V, C\u00e1stro-S\u00e1nchez S, et al. Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension. Sci Rep. 2017;7:1923.", "ArticleIdList": ["PMC5432510", "28507310"]}, {"Citation": "Matsukawa N, Grzesik WJ, Takahashi N, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Nat Acad Sci. 1999;96(13):7403\u20137408.", "ArticleIdList": ["PMC22098", "10377427"]}, {"Citation": "Egom EE, Feridooni T, Pharithi RB, et al. Erratum: new insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int J Physiol Pathophysiol Pharmacol. 2017;9(5):164.", "ArticleIdList": ["PMC5698694", "29218116"]}, {"Citation": "Egom EE-A, Feridooni T, Pharithi RB, et al. New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease. Int J Physiol Pathophysiol Pharmacol. 2017;9(4):112\u2013118.", "ArticleIdList": ["PMC5592245", "28951773"]}, {"Citation": "Gr\u00fcnig E, Mereles D, Arnold K, et al. Primary pulmonary hypertension is predominantly a hereditary disease. Chest. 2002;121(3 Suppl):81s\u201382s.", "ArticleIdList": ["11893705"]}, {"Citation": "Aldred MA, Comhair SA, Varella-Garcia M, et al. Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;182(9):1153\u20131160.", "ArticleIdList": ["PMC3001257", "20581168"]}, {"Citation": "Watson IR, Takahashi K, Futreal PA, Chin L. Emerging patterns of somatic mutations in cancer. Nat Rev Genet. 2013;14(10):703\u2013718.", "ArticleIdList": ["PMC4014352", "24022702"]}, {"Citation": "Germain M, Eyries M, Montani D, et al. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet. 2013;45(5):518\u2013521.", "ArticleIdList": ["PMC3983781", "23502781"]}, {"Citation": "White K, Dempsie Y, Nilsen M, Wright AF, Loughlin L, MacLean MR. The serotonin transporter, gender, and 17\u03b2 oestradiol in the development of pulmonary arterial hypertension. Cardiovasc Res. 2011;90(2):373\u2013382.", "ArticleIdList": ["21177701"]}, {"Citation": "West J, Cogan J, Geraci M, et al. Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics. 2008;1(1):45. doi:10.1186/1755-8794-1-45", "ArticleIdList": ["10.1186/1755-8794-1-45", "PMC2561034", "18823550"]}, {"Citation": "Austin ED, Cogan JD, West JD, et al. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J. 2009;34(5):1093\u20131099. doi:10.1183/09031936.00010409", "ArticleIdList": ["10.1183/09031936.00010409", "PMC3742124", "19357154"]}, {"Citation": "Roberts KE, Fallon MB, Krowka MJ, et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med. 2009;179(9):835\u2013842. doi:10.1164/rccm.200809-1472OC", "ArticleIdList": ["10.1164/rccm.200809-1472OC", "PMC2675568", "19218192"]}, {"Citation": "Archer SL, Marsboom G, Kim GH, et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation. 2010;121(24):2661\u20132671. doi:10.1161/CIRCULATIONAHA.109.916098", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.916098", "PMC2914302", "20529999"]}, {"Citation": "White K, Loscalzo J, Chan SY. Holding our breath: the emerging and anticipated roles of microRNA in pulmonary hypertension. Pulm Circ. 2012;2(3):278\u2013290. doi:10.4103/2045-8932.101395", "ArticleIdList": ["10.4103/2045-8932.101395", "PMC3487298", "23130098"]}, {"Citation": "Meloche J, Pflieger A, Vaillancourt M, et al. Role for DNA damage signaling in pulmonary arterial hypertension. Circulation. 2014;129(7):786\u2013797. doi:10.1161/CIRCULATIONAHA.113.006167", "ArticleIdList": ["10.1161/CIRCULATIONAHA.113.006167", "24270264"]}, {"Citation": "Brock M, Trenkmann M, Gay RE, et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type ii through a novel STAT3\u2013microRNA Cluster 17/92 Pathway. Circ Res. 2009;104(10):1184\u20131191. doi:10.1161/CIRCRESAHA.109.197491", "ArticleIdList": ["10.1161/CIRCRESAHA.109.197491", "19390056"]}, {"Citation": "Long L, Ormiston ML, Yang X, et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med. 2015;21(7):777\u2013785. doi:10.1038/nm.3877", "ArticleIdList": ["10.1038/nm.3877", "PMC4496295", "26076038"]}, {"Citation": "Morrell NW, Aldred MA, Chung WK, et al. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1. doi:10.1183/13993003.01899-2018", "ArticleIdList": ["10.1183/13993003.01899-2018", "PMC6351337", "30545973"]}, {"Citation": "Drake KM, Dunmore BJ, McNelly LN, Morrell NW, Aldred MA. Correction of Nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2013;49(3):403\u2013409. doi:10.1165/rcmb.2013-0100OC", "ArticleIdList": ["10.1165/rcmb.2013-0100OC", "PMC3824059", "23590310"]}, {"Citation": "Long L, Yang X, Southwood M, et al. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res. 2013;112(8):1159\u20131170. doi:10.1161/CIRCRESAHA.111.300483", "ArticleIdList": ["10.1161/CIRCRESAHA.111.300483", "23446737"]}, {"Citation": "Dunmore BJ, Drake KM, Upton PD, Toshner MR, Aldred MA, Morrell NW. The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations. Hum Mol Genet. 2013;22(18):3667\u20133679.", "ArticleIdList": ["PMC3749859", "23669347"]}, {"Citation": "Hurst LA, Dunmore BJ, Long L, et al. TNF\u03b1 drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. Nat Commun. 2017;8:14079.", "ArticleIdList": ["PMC5241886", "28084316"]}, {"Citation": "Nickel NP, Spiekerkoetter E, Gu M, et al. Elafin reverses pulmonary hypertension via caveolin-1-dependent bone morphogenetic protein signaling. Am J Respir Crit Care Med. 2015;191(11):1273\u20131286.", "ArticleIdList": ["PMC4476518", "25853696"]}, {"Citation": "Spiekerkoetter E, Tian X, Cai J, et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest. 2013;123(8):3600\u20133613.", "ArticleIdList": ["PMC3726153", "23867624"]}, {"Citation": "Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. The 6th World Symposium on Pulmonary Hypertension: what\u2019s old is new. F1000Research. 2019;8.", "ArticleIdList": ["PMC6584967", "31249672"]}, {"Citation": "McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1 Suppl):14s\u201334s.", "ArticleIdList": ["15249493"]}, {"Citation": "Quest AFG, Leyton L, P\u00e1rraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol. 2004;82(1):129\u2013144.", "ArticleIdList": ["15052333"]}, {"Citation": "Ketchum KA, Joiner WJ, Sellers AJ, Kaczmarek LK, Goldstein SAN. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature. 1995;376(6542):690\u2013695.", "ArticleIdList": ["7651518"]}, {"Citation": "Ma L, Chung WK. The role of genetics in pulmonary arterial hypertension. J Pathol. 2017;241(2):273\u2013280.", "ArticleIdList": ["PMC5167647", "27770446"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "5"}, {"Year": "2021", "Month": "2", "Day": "18"}, {"Year": "2021", "Month": "3", "Day": "18", "Hour": "6", "Minute": "45"}, {"Year": "2021", "Month": "3", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "19", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["33732008", "PMC7958998", "10.2147/TACG.S260755", "260755"]}}], "PubmedBookArticle": []}